#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Follicular lymphoma stage I Adenocarcinoma pancreas Chronic lymphocytic leukaemia recurrent Thalassaemia beta Plasma cell myeloma refractory Urethral valves Henoch-Schonlein purpura Renal disorder Pericarditis Cluster headache Epileptic encephalopathy Squamous cell carcinoma of head and neck Sexually transmitted disease Metastatic malignant melanoma Antisynthetase syndrome More trials…

    Learn about Rare Diseases

    Lennox-Gastaut syndrome – Trials in Disease Fragile X syndrome – Basic Information Antisynthetase syndrome – Life with Disease Langerhans’ cell histiocytosis – Basic Information Nephrotic syndrome – Basic Information Ewing’s sarcoma – Basic Information Lymphangioma – Treatment Soft tissue sarcoma Chondrosarcoma metastatic – Trials in Disease Haemolytic uraemic syndrome – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    L-Histidine Hydrochloride Nilotinib Pegenzileukin Testosterone Carbetocin Cat Epithelia AAV9-CTNT-COBAG3 Immunostimulants Ripasudil Panitumumab LY3372993 Lucerastat Mva-209-Fsp-B2 Atogepant Calcitriol Fluticasone Ceftolozane Gadoxetic Acid, Disodium Tiotropium Bromide Elezanumab More therapies…

    Learn about Your Condition

    Deafness bilateral Obstructive pancreatitis Pancreatic carcinoma recurrent Gender dysphoria Rhabdomyosarcoma recurrent Oedema peripheral Wolfram syndrome Actinic keratosis Cutaneous calcification Graves' disease Pruritus Otitis media Mucous membrane pemphigoid Glomerulonephritis acute Electrocorticogram More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Dementia Alzheimer’s type

  • Study on BIIB080 for Patients Aged 50-80 with Mild Cognitive Impairment or Mild Alzheimer’s Disease Dementia

    Not yet recruiting

    2 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Flutemetamol (18F)
    • Florbetaben (18F)
    Belgium Czechia Denmark Finland France Germany +5

  • Study on JNJ-64042056 for Preclinical Alzheimer’s Disease in Patients

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • 6-(Fluoro-18F)-3-(1H-Pyrrolo[2,3-C]Pyridin-1-Yl)-5-Isoquinolinamine
    • Jnj-64042056
    Belgium France Germany Spain Sweden

  • Oral Semaglutide in People With Mild Cognitive Impairment or Mild Dementia of the Alzheimer’s Type

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Semaglutide
    Austria Belgium Bulgaria Czechia Denmark Finland +15

  • Study of Trontinemab Compared to Placebo for Patients with Early Symptomatic Alzheimer’s Disease

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Flutemetamol (18F)
    • TRONTINEMAB
    • Florbetaben (18F)
    Denmark France Germany Italy The Netherlands Poland +1

  • A study testing trontinemab compared to placebo in patients with early Alzheimer’s disease including mild cognitive impairment and mild dementia

    Not recruiting

    3 1 1
    Investigated Drugs:
    • Flutemetamol (18F)
    • TRONTINEMAB
    • Florbetaben (18F)
    Denmark France Germany Italy Poland Spain

  • A study testing MK-1167 added to current treatment in patients with mild to moderate Alzheimer’s disease dementia

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Mk-1167
    Italy The Netherlands Spain
Previous Page
1 … 7 8 9 10 11 … 15
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!